Plasma endogenous opioids and dexamethasone suppression test in depression
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Psychiatry Research
- Vol. 21 (2) , 151-159
- https://doi.org/10.1016/0165-1781(87)90072-2
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Dexamethasone suppression test as a simple measure of stress?BMJ, 1985
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- Correlation between beta-endorphin/beta-lipotropin-immunoreactivity and cortisol plasma concentrationsLife Sciences, 1984
- Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in DepressionNew England Journal of Medicine, 1984
- The Limited Utility of the Dexamethasone Suppression Test for the Diagnostic Process in PsychiatryThe British Journal of Psychiatry, 1984
- Opioid Plasma Levels in Primary Affective DisordersNeuropsychobiology, 1984
- The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health workshopPublished by American Medical Association (AMA) ,1983
- Plasma beta-endorphin-like immunoreactivity, self reported pain perception and anxiety levels in women during pregnancy and laborLife Sciences, 1982
- Plasma measures of B-endorphin-like immunoreactivity in depressives and other psychiatric subjectsLife Sciences, 1982
- β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary GlandScience, 1977